Vericel (VCEL) EBIT Margin (2011 - 2026)
Vericel recorded quarterly EBIT Margin of 11.79% in Q1 2026, down 148.85% quarter-over-quarter from 24.12% in Q4 2025, and up 1254.0% year-over-year from 0.87% in Q1 2025.
Vericel's EBIT Margin history runs 16 years deep, the most recent figure standing at 11.79% for Q1 2026.
- In Q1 2026, EBIT Margin rose 1254.0% year-over-year to 11.79%; the TTM figure through Mar 2026 stood at 5.4% (up 658.0% YoY), while the FY2025 annual figure was 4.0%, up 209.0% from the prior year.
- EBIT Margin came in at 11.79% for Q1 2026 at Vericel, down from 24.12% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 24.52% in Q4 2024 to a low of 24.52% in Q2 2022.
- A 5-year average of 5.13% and a median of 11.09% in 2023 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin slumped 1508 bps in 2022 and surged 1254 bps in 2026, its largest moves.
- Vericel's EBIT Margin stood at 11.55% in 2022, then jumped by 70 bps to 19.59% in 2023, then climbed by 25 bps to 24.52% in 2024, then decreased by 2 bps to 24.12% in 2025, then sank by 149 bps to 11.79% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 11.79%, 24.12%, and 5.11% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | -11.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.79% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -3.21% |
| Mar 31, 2025 | -24.32% |
| Dec 31, 2024 | 24.52% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | -11.45% |
| Mar 31, 2024 | -10.66% |
| Dec 31, 2023 | 19.59% |
| Sep 30, 2023 | -11.09% |
| Jun 30, 2023 | -12.98% |
| Mar 31, 2023 | -19.94% |
| Dec 31, 2022 | 11.55% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -24.52% |
| Mar 31, 2022 | -20.29% |
| Dec 31, 2021 | 8.70% |
| Sep 30, 2021 | -14.38% |
| Jun 30, 2021 | -9.44% |
| Mar 31, 2021 | -9.83% |
| Dec 31, 2020 | 27.17% |
| Sep 30, 2020 | 10.90% |
| Jun 30, 2020 | -41.76% |
| Mar 31, 2020 | -19.03% |
| Dec 31, 2019 | 23.38% |
| Sep 30, 2019 | 10.15% |
| Jun 30, 2019 | -77.24% |
| Mar 31, 2019 | -15.40% |
| Dec 31, 2018 | 19.13% |
| Sep 30, 2018 | -5.94% |
| Jun 30, 2018 | -22.33% |
| Mar 31, 2018 | -23.98% |
| Dec 31, 2017 | 5.10% |
| Sep 30, 2017 | -28.27% |
| Jun 30, 2017 | -14.87% |
| Mar 31, 2017 | -102.80% |
| Dec 31, 2016 | 5.10% |
| Sep 30, 2016 | -58.38% |
| Jun 30, 2016 | -38.87% |
| Mar 31, 2016 | -14.12% |
| Dec 31, 2015 | -32.15% |
| Sep 30, 2015 | -43.12% |
| Jun 30, 2015 | -16.67% |
| Mar 31, 2015 | -42.14% |
| Dec 31, 2014 | -15.95% |
| Sep 30, 2014 | -83.06% |
| Jun 30, 2014 | -192.28% |
| Dec 31, 2013 | -61,550.00% |
| Jun 30, 2013 | -174,466.67% |
| Mar 31, 2013 | -89,562.50% |
| Dec 31, 2012 | -40,089.47% |
| Mar 31, 2012 | -427,900.00% |
| Sep 30, 2011 | -82,655.56% |
| Mar 31, 2011 | -69,555.56% |